PIM kinase is consequently emerging as a promising target for cancer therapeutics and immunomodulation. kinases are overexpressed in variety of hematological malignancies solid tumors, their inhibition has become strong therapeutic interest. Currently, some pan-PIM inhibitors being developed under different phases clinical trials. Based on the scaffold structures, they can be classified into va...